Verition Fund Management
ARCT icon

Verition Fund Management’s Arcturus Therapeutics ARCT Stock Holding History

Verition Fund Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-63,184
Closed -$822K – 3742
2025
Q2 		$822K Buy
+63,184
New +$747K ﹤0.01% 2610
2025
Q1 		– Sell
-10,599
Closed -$180K – 3312
2024
Q4 		$180K Sell
10,599
-7,514
-41% -$141K ﹤0.01% 3002
2024
Q3 		$420K Buy
+18,113
New +$387K ﹤0.01% 2426
2015
Q2 		– Sell
-7,900
Closed -$311K – 607
2015
Q1 		$311K Sell
7,900
-7,914
-50% -$348K 0.09% 192
2014
Q4 		$413K Hold
15,814
– – 0.11% 104
2014
Q3 		$1.71M Hold
15,814
– – 0.32% 58
2014
Q2 		$1.92M Sell
15,814
-28,513
-64% -$3.44M 0.32% 66
2014
Q1 		$5.63M Buy
+44,327
New +$6.57M 1.26% 17

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return